Cargando…

The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass

BACKGROUND AND OBJECTIVES: Nociceptin/Orphanin FQ (N/OFQ) is a non-classical endogenous opioid peptide that modulates immune function in vitro. Its importance in inflammation and human sepsis is unknown. The objectives of this study were to determine the relationship between N/OFQ, transcripts for i...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Jonathan P., Serrano-Gomez, Alcira, McDonald, John, Ladak, Nadia, Bowrey, Sarah, Lambert, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790749/
https://www.ncbi.nlm.nih.gov/pubmed/24124588
http://dx.doi.org/10.1371/journal.pone.0076682
_version_ 1782286639302705152
author Thompson, Jonathan P.
Serrano-Gomez, Alcira
McDonald, John
Ladak, Nadia
Bowrey, Sarah
Lambert, David G.
author_facet Thompson, Jonathan P.
Serrano-Gomez, Alcira
McDonald, John
Ladak, Nadia
Bowrey, Sarah
Lambert, David G.
author_sort Thompson, Jonathan P.
collection PubMed
description BACKGROUND AND OBJECTIVES: Nociceptin/Orphanin FQ (N/OFQ) is a non-classical endogenous opioid peptide that modulates immune function in vitro. Its importance in inflammation and human sepsis is unknown. The objectives of this study were to determine the relationship between N/OFQ, transcripts for its precursor (pre-pro-N/OFQ [ppNOC]) and receptor (NOP), inflammatory markers and clinical outcomes in patients undergoing cardiopulmonary bypass and with sepsis. METHODS: A prospective observational cohort study of 82 patients admitted to Intensive Care (ICU) with sepsis and 40 patients undergoing cardiac surgery under cardiopulmonary bypass (as a model of systemic inflammation). Sixty three healthy volunteers, matched by age and sex to the patients with sepsis were also studied. Clinical and laboratory details were recorded. Polymorph ppNOC and NOP receptor mRNA were determined using quantitative PCR. Plasma N/OFQ was determined using ELISA and cytokines (TNF- α, IL-8, IL-10) measured using radioimmunoassay. Data from patients undergoing cardiac surgery were recorded before, 3 and 24 hours after cardiopulmonary bypass. ICU patients with sepsis were assessed on Days 1 and 2 of ICU admission, and after clinical recovery. MAIN RESULTS: Plasma N/OFQ concentrations increased (p<0.0001) on Days 1 and 2 of ICU admission with sepsis compared to matched recovery samples. Polymorph ppNOC (p= 0.019) and NOP mRNA (p<0.0001) decreased compared to healthy volunteers. TNF-α, IL-8 and IL-10 concentrations increased on Day 1 compared to matched recovery samples and volunteers (p<0.0001). Similar changes (increased plasma N/OFQ, [p=0.0058], decreased ppNOC [p<0.0001], increased IL-8 and IL-10 concentrations [both p<0.0001]) occurred after cardiac surgery but these were comparatively lower and of shorter duration. CONCLUSIONS: The N/OFQ system is modulated in ICU patients with sepsis with similar but reduced changes after cardiac surgery under cardiopulmonary bypass. Further studies are required to clarify the role of the N/OFQ system in inflammation and sepsis, and the mechanisms involved.
format Online
Article
Text
id pubmed-3790749
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37907492013-10-11 The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass Thompson, Jonathan P. Serrano-Gomez, Alcira McDonald, John Ladak, Nadia Bowrey, Sarah Lambert, David G. PLoS One Research Article BACKGROUND AND OBJECTIVES: Nociceptin/Orphanin FQ (N/OFQ) is a non-classical endogenous opioid peptide that modulates immune function in vitro. Its importance in inflammation and human sepsis is unknown. The objectives of this study were to determine the relationship between N/OFQ, transcripts for its precursor (pre-pro-N/OFQ [ppNOC]) and receptor (NOP), inflammatory markers and clinical outcomes in patients undergoing cardiopulmonary bypass and with sepsis. METHODS: A prospective observational cohort study of 82 patients admitted to Intensive Care (ICU) with sepsis and 40 patients undergoing cardiac surgery under cardiopulmonary bypass (as a model of systemic inflammation). Sixty three healthy volunteers, matched by age and sex to the patients with sepsis were also studied. Clinical and laboratory details were recorded. Polymorph ppNOC and NOP receptor mRNA were determined using quantitative PCR. Plasma N/OFQ was determined using ELISA and cytokines (TNF- α, IL-8, IL-10) measured using radioimmunoassay. Data from patients undergoing cardiac surgery were recorded before, 3 and 24 hours after cardiopulmonary bypass. ICU patients with sepsis were assessed on Days 1 and 2 of ICU admission, and after clinical recovery. MAIN RESULTS: Plasma N/OFQ concentrations increased (p<0.0001) on Days 1 and 2 of ICU admission with sepsis compared to matched recovery samples. Polymorph ppNOC (p= 0.019) and NOP mRNA (p<0.0001) decreased compared to healthy volunteers. TNF-α, IL-8 and IL-10 concentrations increased on Day 1 compared to matched recovery samples and volunteers (p<0.0001). Similar changes (increased plasma N/OFQ, [p=0.0058], decreased ppNOC [p<0.0001], increased IL-8 and IL-10 concentrations [both p<0.0001]) occurred after cardiac surgery but these were comparatively lower and of shorter duration. CONCLUSIONS: The N/OFQ system is modulated in ICU patients with sepsis with similar but reduced changes after cardiac surgery under cardiopulmonary bypass. Further studies are required to clarify the role of the N/OFQ system in inflammation and sepsis, and the mechanisms involved. Public Library of Science 2013-10-04 /pmc/articles/PMC3790749/ /pubmed/24124588 http://dx.doi.org/10.1371/journal.pone.0076682 Text en © 2013 Thompson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Thompson, Jonathan P.
Serrano-Gomez, Alcira
McDonald, John
Ladak, Nadia
Bowrey, Sarah
Lambert, David G.
The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass
title The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass
title_full The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass
title_fullStr The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass
title_full_unstemmed The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass
title_short The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass
title_sort nociceptin/orphanin fq system is modulated in patients admitted to icu with sepsis and after cardiopulmonary bypass
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790749/
https://www.ncbi.nlm.nih.gov/pubmed/24124588
http://dx.doi.org/10.1371/journal.pone.0076682
work_keys_str_mv AT thompsonjonathanp thenociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT serranogomezalcira thenociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT mcdonaldjohn thenociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT ladaknadia thenociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT bowreysarah thenociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT lambertdavidg thenociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT thompsonjonathanp nociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT serranogomezalcira nociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT mcdonaldjohn nociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT ladaknadia nociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT bowreysarah nociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass
AT lambertdavidg nociceptinorphaninfqsystemismodulatedinpatientsadmittedtoicuwithsepsisandaftercardiopulmonarybypass